REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a...
Related Keywords
New York , United States , Chen Schor , Janhavi Mohite , Anne Bowdidge , Adicet Bio , Nasdaq , Adicet Bio Inc , Stern Investor Relations Inc , Chief Executive Officer , Guggenheim Healthcare Talks , Annual Biotechnology Conference , Investor Relations ,
comparemela.com © 2020. All Rights Reserved.